Anoxia/reoxygenation Injury in Hepatocytes is Not Prevented by Calcium Channel Blockers
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Binding and distribution of three prototype calcium channel blockers in perfused rat liver.
Bikhazi A, Bitar K, Kreydiyyeh S, Saleh R, El-Kasti M, Ibrahim M Mol Cell Biochem. 1997; 169(1-2):1-11.
PMID: 9089625 DOI: 10.1023/a:1006879823866.
References
1.
Takei Y, Marzi I, Kauffman F, Currin R, Lemasters J, Thurman R
. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine. Transplantation. 1990; 50(1):14-20.
DOI: 10.1097/00007890-199007000-00003.
View
2.
Borle A, Snowdowne K
. Measurement of intracellular ionized calcium with aequorin. Methods Enzymol. 1986; 124:90-116.
DOI: 10.1016/0076-6879(86)24011-2.
View
3.
Landon E, Naukam R, RAMA SASTRY B
. Effects of calcium channel blocking agents on calcium and centrilobular necrosis in the liver of rats treated with hepatotoxic agents. Biochem Pharmacol. 1986; 35(4):697-705.
DOI: 10.1016/0006-2952(86)90369-2.
View
4.
Studer R, Borle A
. Differences between male and female rats in the regulation of hepatic glycogenolysis. The relative role of calcium and cAMP in phosphorylase activation by catecholamines. J Biol Chem. 1982; 257(14):7987-93.
View